San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.
Treating the Chest with Care on a Transgender Patient
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023
Establishing a Culture of Respect: Responding to Patient-Initiated Harassment
2 Clarke Drive Cranbury, NJ 08512